[1] 秦叔逵,方瑜,王琳,等. c-Met、VEGF、EGFR和HER-2在AFP阳性胃癌中的表达研究[J].中国癌症杂志,2016,26(8):662-669. [2] 胡剑浩,陈魏燕,王秀芳,等. 胰岛素样生长因子结合蛋白7对胃癌细胞株SGC-7901细胞周期的影响[J].温州医科大学学报,2017,47(4):296-298. [3] Abbas M, Ahmed A, Khan GJ,et al. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer[J].Curr Probl Cancer,2018,43(1):5-17. [4] Wei Y, Yu D, Li Y, et al. Laparoscopic versus open gastrectomy for advanced gastric cancer: A meta-analysis based on high-quality retrospective studies and clinical randomized trials[J].Clin Res Hepatol Gastroenterol,2018,42(6):577-590. [5] Esaki M, Suzuki S, Hayashi Y, et al. Propensity score-matching analysis to compare clinical outcomes of endoscopic submucosal dissection for early gastric cancer in the postoperative and non-operative stomachs[J].BMC Gastroenterol,2018,18(1):90-93. [6] 马桂芳,刘冉,李云晖. 肝细胞生长因子受体在肿瘤中的研究进展[J].癌变?畸变?突变,2015,27(3):242-244. [7] 贺德志,韩艳妙,李建生. 胰岛素样生长因子结合蛋白7基因对胃癌细胞周期和体内外增殖的影响[J].中华消化杂志,2016,36(11):746-751. [8] 罗玉政,陈波,李红樱. 沉默IGF1R表达对胃癌细胞侵袭与迁移能力的影响及机制[J].中国临床研究,2018,31(2):163-166. [9] 张海峰,申兴斌,刘莎莎,等. IGF-1及IGF-1R在胃癌中的表达及意义[J].中国微生态学杂志,2016,28(12):1440-1442. [10] 巢晨,马贵亮,任红,等. 携带人肝细胞生长因子第一结构域基因溶瘤腺病毒的构建及其对胃癌细胞的杀伤作用[J].中华实验外科杂志,2017,34(6):973-975. [11] 高云鹤,崔建新,郗洪庆,等. 胰岛素样生长因子受体-1在胃癌中的表达及与患者预后关系的Meta分析[J].中华胃肠外科杂志,2015,25(10):1051-1055. [12] 陈旭艳,吴芳,于红刚. 胃癌手术前后血清肝细胞生长因子动态变化及其与肝转移的关系[J].中华生物医学工程杂志,2016,22(6):492-495.
2019, Vol. 36 
